Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection.
Moreno-García E, Rico E, Albiach L, Agüero D, Ambrosioni J, Bodro M, Cardozo C, Chumbita M, De la Mora M, García-Pouton N, Garcia-Vidal C, González-Cordón A, Hernández-Meneses M, Inciarte A, Laguno M, Leal L, Linares L, Macay I, Meira F, Mensa J, Moreno A, Morata L, Puerta-Alcalde P, Rojas J, Solá M, Torres B, Torres M, Tomé A, Tuset M, Castro P, Fernández S, Nicolás JM, Almuedo-Riera A, Muñoz J, Fernandez-Pittol M, Marcos MA, Soy D, Martínez JA, García F, Soriano A.
Moreno-García E, et al. Among authors: de la mora m.
Rev Esp Quimioter. 2021 Jun;34(3):238-244. doi: 10.37201/req/037.2021. Epub 2021 Apr 7.
Rev Esp Quimioter. 2021.
PMID: 33829722
Free PMC article.